The net purchase of 11 shares was more than 100 million yuan, and Wuxi apptec was the most
According to wind statistics, a total of 1093 stocks were net purchased by financing on December 15, and 297 stocks with a net purchase amount of more than 10 million yuan. Among them, 11 financing net purchases exceeded 100 million yuan. Wuxi apptec's net purchase of financing ranked first, with a net purchase of 542 million yuan on the same day; Followed by DEA shares, with a net purchase of 334 million yuan. Wuliangye, JAC, Guizhou Maotai, Guodian Nari, Sifang shares, Three Gorges energy, Guolian securities, Ping An Bank and other shares were financed with a net purchase amount of more than 100 million yuan.
This text is a result of machine translation.
Related companies：
Briefing Jun 28, 2022 12:09 PM
· Real Estate
The second batch of homesteads sold intensively in Shanghai this year began to trade 32 plots from July 25, reducing the quantity and improving the quality
In-depth
Technology, Consumer Staples
Smart IoT Device Brings Future Homes into Focus, but Sparks with Interoperability Issue
With the dawn of home automation having been heralded for years, the 'smart' label of in-home products as forthcoming additions has become ubiquitous in the sustainable technology market. Global companies sought to further underline their credentials in home automation which led to a massive stretch of the imagination from smart light bulbs and thermostats to doorbells.
Jun 02, 2022 10:07 PM
Briefing Jun 25, 2022 06:50 AM
In the half year, the 36billion yuan production expansion plan has been thrown away, and the competition in the stock market of Baijiu is fierce
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
May 20, 2021 07:23 PM
Apr 22, 2021 03:11 PM
Briefing Jun 24, 2022 10:29 AM
· Consumer Staples
Dongbei group: the holding foundry subsidiary currently produces brake discs and other products at full capacity, with orders in short supply
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing Jun 24, 2022 07:24 AM
· Real Estate
Financial associated press commentary: don't rush to deny the "wheat house exchange"
Briefing Jun 23, 2022 02:03 PM
· Industrials
Samsung and apple smartphones began to enter Russia through parallel import channels
Briefing Jun 19, 2022 01:29 PM
Xiaomi 618's Omni channel payment exceeded 18.7 billion yuan
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth